109.85
0.15%
-0.16
전일 마감가:
$110.01
열려 있는:
$110.14
하루 거래량:
570.40K
시가총액:
$6.92B
수익:
$3.83B
순이익/손실:
$414.83M
주가수익비율:
-69.97
EPS:
-1.57
순현금흐름:
$1.05B
1주 성능:
-1.23%
1개월 성능:
-5.64%
6개월 성능:
-17.28%
1년 성능:
-21.20%
Jazz Pharmaceuticals plc Stock (JAZZ) Company Profile
명칭
Jazz Pharmaceuticals plc
전화
353 1 634 7800
주소
Waterloo Exchange, Fifth Floor Waterloo Road, Dublin
Jazz Pharmaceuticals plc Stock (JAZZ) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-01-03 | 개시 | Robert W. Baird | Outperform |
2023-11-27 | 다운그레이드 | UBS | Buy → Neutral |
2023-09-29 | 개시 | Raymond James | Mkt Perform |
2023-06-12 | 재개 | Wells Fargo | Equal Weight |
2022-12-09 | 업그레이드 | Goldman | Neutral → Buy |
2022-06-14 | 개시 | UBS | Buy |
2022-04-06 | 다운그레이드 | Goldman | Buy → Neutral |
2021-11-19 | 재개 | Goldman | Buy |
2021-10-07 | 재개 | Jefferies | Buy |
2021-10-05 | 개시 | Citigroup | Buy |
2021-09-23 | 개시 | Needham | Buy |
2021-05-19 | 재개 | JP Morgan | Overweight |
2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
2021-02-05 | 재확인 | H.C. Wainwright | Buy |
2021-02-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2021-01-29 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2020-12-16 | 개시 | UBS | Buy |
2020-11-03 | 재확인 | H.C. Wainwright | Buy |
2020-10-09 | 재확인 | H.C. Wainwright | Buy |
2020-09-14 | 다운그레이드 | Goldman | Neutral → Sell |
2020-09-14 | 재개 | JP Morgan | Overweight |
2020-08-06 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2020-07-28 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
2020-07-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2020-04-06 | 개시 | Jefferies | Buy |
2020-03-12 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
2020-01-08 | 개시 | Goldman | Neutral |
2019-08-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
2019-06-11 | 개시 | Barclays | Overweight |
2019-03-20 | 개시 | SunTrust | Buy |
2018-12-14 | 개시 | Wolfe Research | Peer Perform |
2018-11-08 | 재확인 | B. Riley FBR | Buy |
2018-08-08 | 재확인 | Stifel | Buy |
2018-07-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2018-03-23 | 재확인 | H.C. Wainwright | Neutral |
2018-03-19 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Jazz Pharmaceuticals plc 주식(JAZZ)의 최신 뉴스
Jazz (JAZZ) International Revenue Performance Explored
Zacks Investment Research
Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
Zacks Investment Research
Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews
Benzinga
Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research
Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks Investment Research
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks Investment Research
Jazz Pharmaceuticals plc (JAZZ) 재무 분석
Jazz Pharmaceuticals plc (JAZZ) 매출 2024
JAZZ은 2023-12-31 종료 분기에 대해 매출(지난 12개월)이 3.83B 달러로 보고했으며, 전년대비 +4.78% 상승했습니다.
Jazz Pharmaceuticals plc (JAZZ) 순이익 2024
JAZZ은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 414.83M 달러로 보고했으며, 전년대비 +285.14% 증가했습니다.
Jazz Pharmaceuticals plc (JAZZ) 현금흐름 2024
2023-12-31 종료 분기에 JAZZ은 현금흐름(지난 12개월)으로 1.05B 달러를 기록했으며, 전년 대비 +35.57% 증가했습니다.
Jazz Pharmaceuticals plc (JAZZ) 주당 순이익 2024
JAZZ이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 6.12달러이며, 전년 대비 +272.39% 성장했습니다.
Jazz Pharmaceuticals plc 주식 (JAZZ) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Carr Patricia | SVP, Chief Accounting Officer |
Mar 07 '24 |
Sale |
116.98 |
1,768 |
206,821 |
6,596 |
Carr Patricia | SVP, Chief Accounting Officer |
Mar 06 '24 |
Sale |
119.64 |
1,936 |
231,628 |
8,364 |
Johnson Philip L | EVP & Chief Financial Officer |
Mar 01 '24 |
Buy |
119.65 |
12,000 |
1,435,800 |
27,932 |
Cook Jennifer E. | Director |
Dec 04 '23 |
Sale |
119.27 |
417 |
49,736 |
6,888 |
Smith Mark Douglas | Director |
Dec 04 '23 |
Sale |
119.27 |
417 |
49,736 |
6,888 |
Patil Neena M | EVP & Chief Legal Officer |
Sep 01 '23 |
Sale |
144.25 |
1,500 |
216,375 |
29,186 |
Carr Patricia | SVP, Chief Accounting Officer |
Aug 29 '23 |
Sale |
143.47 |
142 |
20,373 |
5,986 |
Patil Neena M | EVP & Chief Legal Officer |
Aug 15 '23 |
Sale |
139.59 |
750 |
104,695 |
30,686 |
McSharry Heather Ann | Director |
Aug 14 '23 |
Sale |
138.16 |
1,344 |
185,685 |
16,778 |
Sohn Catherine A. | Director |
Aug 14 '23 |
Sale |
138.16 |
1,241 |
171,455 |
14,868 |
자본화:
|
볼륨(24시간):